Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- Amid faulty disinfection, coronavirus patients battled deadly, drug-resistant fungus: CDCon January 11, 2021 at 1:19 pm
As if the latest deadly novel pathogen wasn’t enough, the federal health agency recently documented a summer-time outbreak of a serious, multidrug-resistant fungus in a Florida COVID-19 unit.
- Drug-resistant infections: If you can’t beat ‘em, starve ‘em, scientists findon January 7, 2021 at 4:00 pm
BUFFALO, N.Y. — How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers. To ...
- Becker's Clinical Leadership & Infection Control E-Newsletteron January 7, 2021 at 1:10 pm
To sign up for Becker's Clinical Leadership & Infection Control E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need ...
- Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosison January 6, 2021 at 4:01 pm
Mucormycosis is a fungal infection with an often fatal prognosis (1 ... coupled with an inherent tendency for these fungi to be drug resistant (14). Only three antifungal drugs are currently approved ...
- Bacteria-specific phototoxic reactions triggered by blue light and phytochemical carvacrolon January 6, 2021 at 11:15 am
The combination therapy was also effective against mice with either established cutaneous infections or third-degree burn wounds and posed minimal safety risk because of the relatively selective ...
- Mycovia Pharmaceuticals Announces Positive Topline Results from its Third Phase 3 Clinical Trial (ultraVIOLET) of Oteseconazole for the Treatment of Ron January 6, 2021 at 5:30 am
VIOLET Evaluated the Efficacy and Safety of Oteseconazole over 50 weeks -- Efficacy of Oteseconazole Compared to Fluconazole in Treating Acute VVC Infection in Women with RVVC -- NDA Submission ...
- MA Health Officials Express Concern Over New Fungal Superbug In Healthcare Facilitieson January 2, 2021 at 4:36 am
auris, can cause serious bloodstream infections and even death ... since it’s highly drug resistant. “This is the first time we've had a fungal representative in the superbug family,” Mansour said.
- FOSMANOGEPIX: A Novel Broad-Spectrum Antifungal Agent Being Evaluated in Multiple Clinical Trials - Emerging Insight and Market Forecast to 2030 - ResearchAndMarkets.comon December 23, 2020 at 12:34 pm
as well as infections caused by multi-drug-resistant Candida auris, a life-threatening fungal infection recently characterized as an "urgent" threat by the Centers for Disease Control ...
- Global Hospital Infection Therapeutics Market Report 2020-2025on December 21, 2020 at 4:18 am
The antifungal therapeutics include caspofungin ... and pipeline drug molecules that are effective against multi-drug resistant infections and can be used for the treatment of infections with ...
- They warn of fungus in patients hospitalized for COVID-19on December 15, 2020 at 10:13 am
Mexican authorities have reported cases of Candida auris, a drug-resistant fungus that has ... prolonged stay and antibiotic therapy. Five of the infections were reported to have manifested ...
via Bing News